Tags

Type your tag names separated by a space and hit enter

Co-morbidity resolution in morbidly obese children and adolescents undergoing sleeve gastrectomy.
Surg Obes Relat Dis. 2014 Sep-Oct; 10(5):842-50.SO

Abstract

BACKGROUND

Bariatric surgery is becoming important for the reversal of co-morbidities in children and adolescents. We previously reported the safety and efficacy of laparoscopic sleeve gastrectomy (LSG) in the pediatric population. However, evidence pertaining to the effect of LSG on co-morbidities in this age group is scarce. The objective of this study was to assess the remission and improvement of co-morbidities (dyslipidemia, hypertension, diabetes, and obstructive sleep apnea) after LSG in children and adolescents.

METHODS

Anthropometric changes, complications, remission, and improvement in co-morbidities were assessed over 3 years. OSA was diagnosed using the Pediatric Sleep Questionnaire (PSQ) and polysomnography and its resolution was assessed according to PSQ score alone. Diabetes, prediabetes, hypertension, prehypertension, and dyslipidemia were assessed using standard pediatric-specific definitions.

RESULTS

The review yielded 226 patients; 74 patients were prepubertal (5-12 yr of age, mean: 9.8±2.3), 115 adolescents (13-17 yr of age, mean: 15.4±1.7), and 37 were young adults (18-21 yr of age, mean: 19.2±.8). Overall mean age was 14.4±4.0 years (range: 4.94-20.99), and 50.4% were females. Mean body mass index (BMI) and BMI z score were 48.2±10.1 kg/m(2) and 2.99±.35, respectively. Mean BMI z score at 1, 2, and 3 years postoperative was 2.01±.87, 2.00±1.07, and 1.66±.65, respectively. Mean preoperative height was 158.0±15.1 cm, and at 1, 2, and 3 years postoperative, it was 160.3±13.4, 161.4±14.1, and 163.2±11.1, respectively. All patients at different age groups experienced normal growth velocity. Within 2 years of follow-up, 90.3% of co-morbidities were in remission or improved, 64.9% of which were within the first 3 months postoperatively. No further improvement or remission was observed beyond 2 years, and there was no recurrence up to 3 years in patients who were seen in follow-up. The lost to follow-up in each of the 3 years was 4.2%, 7.6%, and 15.3%, respectively.

CONCLUSION

LSG performed on children and adolescents results in remission or improvement of>90% of co-morbidities within 2 years after bariatric surgery with few complications, no mortality, and normal growth.

Authors+Show Affiliations

Department of Surgery and Obesity Chair, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Electronic address: qahtani@yahoo.com.Department of Surgery and Obesity Chair, College of Medicine, King Saud University, Riyadh, Saudi Arabia.Department of Surgery and Obesity Chair, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

25439000

Citation

Alqahtani, Aayed R., et al. "Co-morbidity Resolution in Morbidly Obese Children and Adolescents Undergoing Sleeve Gastrectomy." Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery, vol. 10, no. 5, 2014, pp. 842-50.
Alqahtani AR, Elahmedi MO, Al Qahtani A. Co-morbidity resolution in morbidly obese children and adolescents undergoing sleeve gastrectomy. Surg Obes Relat Dis. 2014;10(5):842-50.
Alqahtani, A. R., Elahmedi, M. O., & Al Qahtani, A. (2014). Co-morbidity resolution in morbidly obese children and adolescents undergoing sleeve gastrectomy. Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery, 10(5), 842-50. https://doi.org/10.1016/j.soard.2014.01.020
Alqahtani AR, Elahmedi MO, Al Qahtani A. Co-morbidity Resolution in Morbidly Obese Children and Adolescents Undergoing Sleeve Gastrectomy. Surg Obes Relat Dis. 2014 Sep-Oct;10(5):842-50. PubMed PMID: 25439000.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Co-morbidity resolution in morbidly obese children and adolescents undergoing sleeve gastrectomy. AU - Alqahtani,Aayed R, AU - Elahmedi,Mohamed O, AU - Al Qahtani,Awadh, Y1 - 2014/01/28/ PY - 2013/10/16/received PY - 2014/01/22/revised PY - 2014/01/22/accepted PY - 2014/12/3/entrez PY - 2014/12/3/pubmed PY - 2015/8/4/medline KW - Bariatric surgery KW - Children KW - Co-morbidity resolution KW - Pediatric KW - Sleeve gastrectomy SP - 842 EP - 50 JF - Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery JO - Surg Obes Relat Dis VL - 10 IS - 5 N2 - BACKGROUND: Bariatric surgery is becoming important for the reversal of co-morbidities in children and adolescents. We previously reported the safety and efficacy of laparoscopic sleeve gastrectomy (LSG) in the pediatric population. However, evidence pertaining to the effect of LSG on co-morbidities in this age group is scarce. The objective of this study was to assess the remission and improvement of co-morbidities (dyslipidemia, hypertension, diabetes, and obstructive sleep apnea) after LSG in children and adolescents. METHODS: Anthropometric changes, complications, remission, and improvement in co-morbidities were assessed over 3 years. OSA was diagnosed using the Pediatric Sleep Questionnaire (PSQ) and polysomnography and its resolution was assessed according to PSQ score alone. Diabetes, prediabetes, hypertension, prehypertension, and dyslipidemia were assessed using standard pediatric-specific definitions. RESULTS: The review yielded 226 patients; 74 patients were prepubertal (5-12 yr of age, mean: 9.8±2.3), 115 adolescents (13-17 yr of age, mean: 15.4±1.7), and 37 were young adults (18-21 yr of age, mean: 19.2±.8). Overall mean age was 14.4±4.0 years (range: 4.94-20.99), and 50.4% were females. Mean body mass index (BMI) and BMI z score were 48.2±10.1 kg/m(2) and 2.99±.35, respectively. Mean BMI z score at 1, 2, and 3 years postoperative was 2.01±.87, 2.00±1.07, and 1.66±.65, respectively. Mean preoperative height was 158.0±15.1 cm, and at 1, 2, and 3 years postoperative, it was 160.3±13.4, 161.4±14.1, and 163.2±11.1, respectively. All patients at different age groups experienced normal growth velocity. Within 2 years of follow-up, 90.3% of co-morbidities were in remission or improved, 64.9% of which were within the first 3 months postoperatively. No further improvement or remission was observed beyond 2 years, and there was no recurrence up to 3 years in patients who were seen in follow-up. The lost to follow-up in each of the 3 years was 4.2%, 7.6%, and 15.3%, respectively. CONCLUSION: LSG performed on children and adolescents results in remission or improvement of>90% of co-morbidities within 2 years after bariatric surgery with few complications, no mortality, and normal growth. SN - 1878-7533 UR - https://www.unboundmedicine.com/medline/citation/25439000/Co_morbidity_resolution_in_morbidly_obese_children_and_adolescents_undergoing_sleeve_gastrectomy_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S1550-7289(14)00030-6 DB - PRIME DP - Unbound Medicine ER -